JCTS Calls for Proven AI That Improves Clinical and Translational Research

JCTS seeks proven, real-world AI that measurably improves clinical and translational research. Submit rigorous methods, outcomes, successes and failures by July 16, 2026.

Categorized in: AI News Science and Research
Published on: Feb 04, 2026
JCTS Calls for Proven AI That Improves Clinical and Translational Research

JCTS call for papers: how AI is advancing clinical and translational research

Date: 03 February 2026

The Journal of Clinical and Translational Science (JCTS) is opening a thematic issue: Artificial Intelligence in Action - Tested and Proven Approaches to Transforming Clinical and Translational Science. The focus is simple: show validated AI that measurably improves clinical or translational research. Methods, data, outcomes, and lessons learned-all on the table.

What JCTS is looking for

  • Validated AI approaches with clear methods, strong datasets, and measurable outcomes that raise effectiveness, efficiency, generalizability, and reliability of clinical and translational research.
  • Proven solutions for scaling the infrastructure and capabilities that enable AI tools across CTS teams and institutions.
  • Real-world evaluations of AI in practice-implementation, effectiveness, efficiency, quality, decision-making, resource allocation, and other CTS outcomes.
  • Critical analyses where AI fell short. Detail the causes-data quality, algorithmic bias, health disparities, generalizability limits, integration issues, or contextual constraints-and what to change next time.
  • Broader findings on trust, interpretability, transparency, sustainability, scalability, reproducibility, generalizability, interoperability, regulatory alignment, and ethical, equitable, cost-effective deployment.
  • Implementation of innovative scientific and research processes that meaningfully use AI tools.
  • Methods that measure and communicate AI uncertainty to stakeholders across the CTS enterprise.
  • Approaches for continuous monitoring and adaptive learning to detect performance drift and sustain accuracy, fairness, and reliability over time.
  • Evaluations of how AI affects the translational science workforce, including clinical partners.
  • Scalable methods for evaluating human-AI collaboration-usability, researcher and participant engagement, and workflow integration.
  • Active engagement of patients and communities as collaborators throughout development and implementation.

Eligible AI domains

All scientifically rigorous AI domains are in scope, including:

  • Predictive modeling (e.g., risk stratification for precision clinical trials)
  • Unsupervised natural language processing (e.g., clinical information extraction without expert annotations for screening, outcomes, or safety signals)
  • Computer vision (e.g., endpoints from medical imaging and digital pathology)
  • Causal inference (e.g., counterfactual modeling, target trial emulation)
  • Generative AI and AI agents (e.g., drafting research documentation, coding assistance, participant or researcher conversational agents)
  • Reinforcement learning (e.g., adaptive treatment strategies and decision support)
  • Multi-modal integration (e.g., combining EHR, imaging, genomic, and other sources)

Where your work can fit

Submissions can span the full translational spectrum-from basic discovery and early algorithm development to clinical integration and population health impact. Priority goes to work that removes a bottleneck in the translational pathway.

  • Innovative AI for trial design
  • Tools and strategies to improve participant recruitment and retention
  • Data harmonization and interoperability methods
  • Decision support systems integrated into clinical workflows
  • Post-market surveillance approaches

What strong manuscripts show

  • Clear problem definition, rigorous methods, and reproducible results with measurable impact.
  • Transparency: datasets, code, and reporting aligned with established guidance where possible (e.g., CONSORT-AI for trials).
  • Evidence of reliability across settings, populations, and time-plus uncertainty estimation, monitoring, and drift mitigation.
  • Thoughtful handling of bias, equity, safety, and governance-including patient and community input.
  • Operational fit: usability, workflow integration, training needs, and workforce implications.

Key dates and how to submit

Deadline for submission: July 16, 2026

For details and submission guidelines, visit the JCTS website: cambridge.org/core/journals/journal-of-clinical-and-translational-science.

Why this call matters

Clinical and translational teams need evidence that AI works under real constraints. This issue aims to surface what actually moves research and care forward-what scales, what sustains, and what translates to better decisions and outcomes.

Getting your team ready

  • Pre-specify metrics and evaluation plans appropriate to the setting.
  • Document uncertainty, monitoring, and guardrails from day one.
  • Plan for data quality, interoperability, and governance as first-class requirements.
  • Include patient, community, and clinical partner feedback throughout development and deployment.

Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)
Advertisement
Stream Watch Guide